Four biotechs hit Wall Street with upsized IPOs, each raising more than $20M over their goals
Four more biotechs have jumped onto Nasdaq, each raising over $20 million more than their initial goals and adding to this year’s record-high total raise …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
